Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of the Performance of the miR Sentinel™ BCa Test in Men and Women Presenting for Initial Diagnosis of Bladder Cancer and the miR Sentinel™ BCR Test to Identify Recurrent Bladder Cancer

NCT04155359 is registered in ClinicalTrials.gov with miR Scientific LLC as lead sponsor.

NCT NCT04155359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04155359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of the Performance of the miR Sentinel™ BCa Test in Men and Women Presenting for Initial Diagnosis of Bladder Cancer and the miR Sentinel™ BCR Test to Identify Recurrent Bladder Cancer
Lead sponsor
miR Scientific LLC
Phase
Observational
Overall status
Unknown status
Start date
October 13, 2020
Completion date
December 31, 2024
Enrollment
444 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer